Ranbaxy in licensing deal with Ethypharm, FranceBS Reporter / Mumbai September 18, 2006Ethypharm India, subsidiary of leading French multinational drug delivery company Ethypharm SA, has signed out-licensing and supply contract agreements for two drug formulations with Ranbaxy Laboratories. The out-licensing deal involves the fixed dose combinations of fenofibrate micronized 160 mg, a drug for lowering triglycerides in cases of Hyperlipidemia, and atorvastatin 10 mg, a drug formulation widely used for manage cholesterol level. Ranbaxy will be launching this combination product in the Indian market under the brand name Storfib.This deal comes in quick succession after a similar deal that Ethypharm had signed with Ranbaxy for out-licensing and supply of Tramadol Flashtab in May this year.The products will be supplied from Ethypharm
